Alpha-synuclein is a cellular ferrireductase.
α-synuclein (αS) is a cellular protein mostly known for the association of its aggregated forms with a variety of diseases that include Parkinson's disease and Dementia with Lewy Bodies. While the role of αS in disease is well documented there is currently no agreement on the physiological function of the normal isoform of the protein. Here we provide strong evidence that αS is a cellular ferrireductase, responsible for reducing iron (III) to bio available iron (II). The recombinant form of the protein has a V(Max) of 2.72 nmols/min/mg and K(m) 23 µM. This activity is also evident in lysates from neuronal cell lines overexpressing αS. This activity is dependent on copper bound to αS as a cofactor and NADH as an electron donor. Overexpression of α-synuclein by cells significantly increases the percentage of iron (II) in cells. The common disease mutations associated with increased susceptibility to PD show no [corrected] differences in activity or iron (II) levels. This discovery may well provide new therapeutic targets for PD and Lewy body dementias.
Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.
Paul
P
Davies
Dima
D
Moualla
David R
DR
Brown
D002460:Cell Line; D003300:Copper; D038181:FMN Reductase / Q000502:physiology*; D006801:Humans; D007501:Iron / Q000378:metabolism*; D007700:Kinetics; D020961:Lewy Body Disease / Q000209:etiology; D009243:NAD; D009474:Neurons / Q000201:enzymology; D010300:Parkinson Disease / Q000209:etiology; D051844:alpha-Synuclein / Q000502:physiology*
D051844:alpha-Synuclein; D009243:NAD; D003300:Copper; D007501:Iron; D038181:FMN Reductase; C023903:ferric citrate iron reductase
Anal Biochem. 2004 Aug 15;331(2):370-5
15265744
Mol Psychiatry. 1998 Nov;3(6):462-5
9857966
Neuron. 2000 Jan;25(1):239-52
10707987
Arch Neurol. 2001 Feb;58(2):186-90
11176955
Cell Biochem Biophys. 2007;47(2):285-99
17652776
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4294-9
15767574
Biochemistry. 2009 Mar 31;48(12):2610-9
19196019
J Am Chem Soc. 2008 Jun 18;130(24):7766-73
18494470
Curr Protein Pept Sci. 2008 Oct;9(5):507-40
18855701
FASEB J. 2009 Aug;23(8):2384-93
19325037
Biochem J. 1999 Jun 15;340 ( Pt 3):821-8
10359669
Hum Mol Genet. 2002 Oct 1;11(20):2395-407
12351575
Neurosci Lett. 2004 Aug 26;367(1):34-9
15308292
J Am Chem Soc. 2008 Sep 3;130(35):11801-12
18693689
J Phys Chem B. 2009 Jul 16;113(28):9551-61
19548659
J Am Chem Soc. 2006 Aug 2;128(30):9893-901
16866548
Biochem Biophys Res Commun. 2007 Jul 20;359(1):115-20
17531952
J Neurochem. 2003 Mar;84(5):1128-42
12603836
Biochim Biophys Acta. 2006 Jan;1764(1):5-12
16338184
Mol Cell Biochem. 1983;53-54(1-2):129-52
6137760
J Neurosci. 2002 Apr 15;22(8):3090-9
11943812
Neuroscientist. 2002 Feb;8(1):22-32
11843096
Inorg Chem. 2006 May 1;45(9):3657-64
16634598
Neurologist. 2004 Mar;10(2):75-81
14998437
Mol Neurobiol. 2005;31(1-3):243-54
15953825
Biochem Biophys Res Commun. 2009 Mar 6;380(2):377-81
19250637
J Am Chem Soc. 2008 Jun 4;130(22):6898-9
18465859
Am J Hematol. 2002 Mar;69(3):164-70
11891802
Int J Mol Sci. 2009 Mar;10(3):724-45
19399218
Life Sci. 1999;65(18-19):1973-6
10576448